ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Neurology

Top Neurology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SALVATORE DANNA MD

Neurology

14,978

$1.1M

914
639 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 29%

$74
Average prescription price

Avg: $231

ANTOINE MITRI MD

Neurology

13,645

$1.55M

1352
970 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$114
Average prescription price

Avg: $231

PHILLIP AHN M.D.

Neurology

11,393

$922K

885
827 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $231

JAMES LIN M.D.

Neurology

9,915

$931K

1131
942 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$94
Average prescription price

Avg: $231

SUNG-UN PARK MD

Neurology

9,880

$660K

592
555 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $231

ROBERT HARBAUGH M.D.

Neurology

9,151

$1.37M

551
471 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$150
Average prescription price

Avg: $231

ARMEN CHERIK M.D.

Neurology

8,989

$1.25M

833
714 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$140
Average prescription price

Avg: $231

IRINA DUKHOVNY MD

Neurology

8,889

$573K

872
853 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $231

DIANA HYLTON MD

Neurology

8,882

$1.09M

558
253 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 29%

$123
Average prescription price

Avg: $231

ANDRES JACOBO-ALATRISTE M.D.

Neurology

8,234

$813K

693
546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$99
Average prescription price

Avg: $231

DANIEL CHANG MD

Neurology

8,164

$1.02M

683
621 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 29%

$124
Average prescription price

Avg: $231

PERMINDER BHATIA MD

Neurology

7,759

$1.37M

741
391 are 65+

19%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$176
Average prescription price

Avg: $231

ILKCAN COKGOR M.D.

Neurology

7,591

$2.35M

651
504 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$310
Average prescription price

Avg: $231

ARNOLD GREENBERG M.D.

Neurology

7,413

$738K

859
655 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$100
Average prescription price

Avg: $231

VLADIMIR RAFANOV MD

Neurology

7,381

$689K

582
391 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 29%

$93
Average prescription price

Avg: $231

MUNTHER HIJAZIN MD

Neurology

6,844

$976K

817
610 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$143
Average prescription price

Avg: $231

RICHARD SHUBIN M.D.

Neurology

6,678

$3.03M

530
339 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 29%

$454
Average prescription price

Avg: $231

ROSA CHOY MD

Neurology

6,614

$623K

504
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 29%

$94
Average prescription price

Avg: $231

KYUNG KIM M.D.

Neurology

6,428

$494K

616
575 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$77
Average prescription price

Avg: $231

GARNIK YEGYAN MD

Neurology

5,958

$1.16M

449
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 29%

$194
Average prescription price

Avg: $231

DAVID HOLSTEIN M.D.

Neurology

5,801

$936K

414
261 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$161
Average prescription price

Avg: $231

NEAL HERMANOWICZ MD

Neurology

5,744

$1.5M

516
463 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$261
Average prescription price

Avg: $231

BHUPAT DESAI M.D.

Neurology

5,516

$1.79M

542
423 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$324
Average prescription price

Avg: $231

JANET CHANCE M.D.

Neurology

5,437

$1.04M

562
487 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$191
Average prescription price

Avg: $231

RAJIV PATHAK M.D.

Neurology

5,379

$654K

553
389 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 29%

$122
Average prescription price

Avg: $231

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank